Ventria Bioscience Competitors and Similar CompaniesClear all

Ventria Bioscience's competitors and similar companies include Travere Therapeutics and Sosei Heptares.
Ventria Bioscience
Ventria Bioscience
Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.
Travere Therapeutics
Travere Therapeutics
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Sosei Heptares
Sosei Heptares
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
Founding Date
Founding Date
1993
Founding Date
2011
Founding Date
1990
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Junction City, US HQ
Aurora, US
Locations
San Diego, US HQ
Dublin, IE
Locations
Tokyo, JP HQ
Dublin, IE
Cambridge, GB
London, GB
Employees
Employees
244% decrease
Employees
46293% increase
Employees
387
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.4 b
Valuation ($)
697 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$490.7m (FY, 2025)
Revenue (est.)
¥29.6b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$10.3m (FY, 2025)
Cost of goods
¥7.3b (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
$480.4m (FY, 2025)
Gross profit
¥24b (FY, 2025)
Net income
Net income
N/A
Net income
($25.5m) (FY, 2025)
Net income
(¥12.5b) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 7.7m
Total funding raised
$ 25m
Total funding raised
$ 65m
For sources of this data, please see the company profile

View Company Profiles

Travere Therapeutics
HQ
San Diego, US
Employees
462

Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
Sosei Heptares
HQ
Tokyo, JP
Employees
387

Sosei Heptares is a biopharmaceutical company that specializes in drug development.

View company